Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Zinc Ion SCHEMBL6032684 | 0.86 | — | — | |
| SCHEMBL16550614 | 0.86 | — | — | |
| Silver SCHEMBL7162821 | 0.86 | — | — | |
| SCHEMBL11812110 | 0.86 | — | — | |
| SCHEMBL11651177 | 0.86 | ALDH1A1 (0.30) | — | |
| SCHEMBL129023 | 0.86 | — | — | |
| Potassium Ion SCHEMBL9267740 | 0.86 | — | — | |
| SCHEMBL11440116 | 0.86 | — | — | |
| SCHEMBL9443287 | 0.86 | ALDH1A1 (0.30) | — | |
| SCHEMBL9326228 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114358084-A | Touch material classification method based on DDQN and generation countermeasure network | 吉林大学 | 2022-04-15 | — | — | CN | claimed |
| CN-109118453-B | Image processing method for background suppression | 西北核技术研究所 | 2022-03-04 | — | — | CN | claimed |
| EP-4647095-B1 | ELECTRONIC ADD-ON MODULE AND ASSEMBLY OF AN ELECTRONIC ADD-ON MODULE AND A DRUG DELIVERY DEVICE | SANOFI SA (FR) | 2026-05-06 | — | — | EP | disclosed |
| WO-2025233436-A1 | ELECTRONIC ADD-ON MODULE AND ASSEMBLY OF AN ELECTRONIC ADD-ON MODULE AND A DRUG DELIVERY DEVICE | SANOFI (FR) | 2025-11-13 | — | — | WO | disclosed |
| EP-4647095-A1 | ELECTRONIC ADD-ON MODULE AND ASSEMBLY OF AN ELECTRONIC ADD-ON MODULE AND A DRUG DELIVERY DEVICE | Sanofi (FR) | 2025-11-12 | — | — | EP | disclosed |
| US-PP36436-P2 | Calluna plant named ‘Lynn’ | Edens Creations BV (NL) | 2025-02-11 | — | — | US | disclosed |
| US-12186538-B1 | Electronic add-on module and assembly of an electronic add-on module and a drug delivery device | SANOFI (FR) | 2025-01-07 | — | — | US | disclosed |
| US-20240369576-A1 | ASSAYS FOR ALPHA-DYSTROGLYCAN GLYCOSYLATION AND METHODS FOR USING SAME | BRIDGEBIO GENE THERAPY RESEARCH, INC. | 2024-11-07 | — | — | US | disclosed |
| CN-118804768-A | Medicine for diseases caused by frame shift mutation | 国立大学法人东海国立大学机构 | 2024-10-18 | — | — | CN | disclosed |
| US-12087909-B2 | High energy batteries and methods of making the same | WATTRII, Inc. (US) | 2024-09-10 | — | — | US | disclosed |
| CN-118613238-A | Control unit, system and method for analyzing the use of compression therapy | 侒捷祐知识产权控股有限公司 | 2024-09-06 | — | — | CN | disclosed |
| US-5019581-A | 5-substituted (4,5-c) imidazopyridine compounds which have useful platelet activating factor antagonistic activity | G. D. SEARLE & CO. (US) | 1991-05-28 | — | — | US | disclosed |
| EP-0344414-A1 | 5-Substitued imidazo[4,5-c]pyridines | G.D. Searle & Co. (US) | 1989-12-06 | — | — | EP | disclosed |
| EP-0293170-A1 | Aminomethylphenolic pyrazines, their preparation and use | ICI AMERICAS INC. (US) | 1988-11-30 | — | — | EP | disclosed |
| EP-0059553-B1 | OCTAHYDROBENZO(F)QUINOLINE COMPOUNDS | SMITHKLINE BECKMAN CORPORATION (US) | 1985-01-09 | — | — | EP | disclosed |
| EP-0052932-B1 | 2-AMINOTETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS HAVING CENTRAL ALPHA1 AGONIST ACTIVITY | SMITHKLINE BECKMAN CORPORATION (US) | 1984-02-22 | — | — | EP | disclosed |
| EP-0059553-A2 | Octahydrobenzo(f)quinoline compounds | SMITHKLINE BECKMAN CORPORATION (US) | 1982-09-08 | — | — | EP | disclosed |
| US-4341786-A | ANTIDEPRESSANTS; ADRENERGIC STIMULANTS | SMITHKLINE CORPORATION (US) | 1982-07-27 | — | — | US | disclosed |
| EP-0052932-A1 | 2-Aminotetralin compounds and pharmaceutical compositions having central alpha1 agonist activity | SMITHKLINE BECKMAN CORPORATION (US) | 1982-06-02 | — | — | EP | disclosed |
| US-4320148-A | ANTIDEPRESSANTS | SMITHKLINE CORPORATION (US) | 1982-03-16 | — | — | US | disclosed |